Union européenne - français - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabète sucré, type 2 - les médicaments utilisés dans le diabète - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 et 5.

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 2.5mg - tirzepatide 2.5mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 5mg - tirzepatide 5mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 7.5mg - tirzepatide 7.5mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 10mg - tirzepatide 10mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 12.5mg - tirzepatide 12.5mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 15mg - tirzepatide 15mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 2.5mg - tirzepatide 2.5mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 5mg - tirzepatide 5mg

Canada - français - Health Canada

eli lilly canada inc - tirzepatide - solution - 7.5mg - tirzepatide 7.5mg